Albendazole
Benzimidazole Derivatives
Sold as ALBENZA
- Drug class
- Benzimidazole Derivatives
- Availability
- Prescription only
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 2
- FDA reports (12 mo)
- 109
Overview
Plain-language summary, compiled from the cited regulatory records
Albendazole is a medication belonging to the benzimidazole derivative class of drugs [1]. It is approved for the treatment of specific parasitic infections in humans [1].
Albendazole is indicated for the treatment of parenchymal neurocysticercosis, which is caused by active lesions resulting from larval forms of the pork tapeworm, *Taenia solium* [1]. It is also used to treat cystic hydatid disease of the liver, lung, and peritoneum, which is caused by the larval form of the dog tapeworm, *Echinococcus granulosus* [1].
In the market, albendazole is available under various brand names, including ALBENZA [1]. There were 109 adverse event reports for this drug in the last 12 months [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 2 | September 30, 2019 |
USUnited States· FDA
2 products
Uses
1 INDICATIONS AND USAGE Albendazole is an anthelmintic drug indicated for: Treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . 1 ) Treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus .
1 Neurocysticercosis Albendazole is indicated for the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium . 2 Hydatid Disease Albendazole is indicated for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus .
How to take
Drug interactions
Known interactions involving Albendazole. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 06b5eefc-0b95-48… · revised September 30, 2019 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.